Severe pulmonary complications after bortezomib treatment in multiple myeloma.
Dun
Xiaoyi
X
Yuan
Zhengang
Z
Fu
Weijun
W
Zhang
Chunyang
C
Hou
Jian
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011379:Prognosis; D011719:Pyrazines / Q000009:adverse effects*; D012131:Respiratory Insufficiency / Q000139:chemically induced*; D015996:Survival Rate
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib